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Different cell/tissue derived extracellular matrix (ECM) display subtle differences that might provide important cues
for proliferation and differentiation of cells in vitro or in vivo. However, the bioactivities of different ECMs in vitro
were not fully understood. In this study, osteoblasts-derived and fibroblast-derived ECM-coated cell culture dishes
were prepared respectively by culturing osteoblastic MC3T3-E1 cells and rat fibroblast then decellularizing the
cultures. We investigated the bioactivities of the two different ECMs coated on cell culture plates using cellular,
biochemical and molecular method. The proliferative activity of the bone marrow-derived mesenchymal stem cells
(BMSCs) cultured on osteoblast-ECM was lower than for BMSCs grown on fibroblast-ECM. Compared with the
BMSCs cultured on fibroblast-derived ECM, the cells grown on osteoblastic ECM showed enhanced alkaline
phosphatase (ALP) activity, higher BMP-2 and osteopontin protein levels, increased secreted calcium content, and
higher levels of runt-related transcriptional factor 2 (Runx 2) and osteocalcin (OCN) mRNA. Knockdown of BMP-2 or
FGF-2 with shRNA transfection hardly effected osteoblastic differentiation or proliferation of MC3T3-E1 seeded on
osteoblast-ECM or fibroblast-ECM. Therefore, the osteoblastic ECM had better osteoinductive potential and lower
proliferative effect than fibroblastic ECM, and the two ECM presented enough bioactivity, knockdown of growth
factors had no significant effect on differentiation and proliferation of re-seeded cells.
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DifferentiationBackground
Extracellular matrix (ECM) secreted by the resident
tissue cells contains various protein fibers interwoven
into a hydrated gel composed of a network of glycosami-
noglycan chains (Nelson and Tien 2006; Badylak 2007,
Badylak et al. 2009). ECMs have been established as
potent regulators of cell function and differentiation
(Adams and Watt 1993; Badylak 2005). It provides me-
chanical support to the growing cells and affects cell
adhesion, proliferation, differentiation, morphology, and
gene expression (Kleinman et al. 2003). In principle, the* Correspondence: yyx19683@126.com; z56717@sohu.com
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in any medium, provided the original work is pECM best represents the native cellular and tissue
microenvironment (Discher et al. 2009).
In recent years, a considerable effort has been put into
the research on in vitro bioactivity of ECM coated on
culture plates. After the cells grown in culture plates are
removed using chemical or physical methods, the
bioactivity of the resultant ECM coated on the dishes can
be easily investigated. The osteogenic cell (MC3T3-E1)-
derived ECM, attached to the plates, promotes the osteo-
genic differentiation of embryonic stem cells seeded on
the ECM (Evans et al. 2010). It has been demonstrated
that cardiac fibroblast-ECM supports early maturation of
ES-derived cardiomyocytes in vitro (Baharvand et al.
2005), and improves proliferate and cellular adhesion of
BMSCs (Sreejit and Verma 2011).
Cell-derived ECM has been fabricated into three-
dimensional scaffolds or reconstituted with scaffolds forOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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Wolchok and Tresco 2010; Lu et al. 2011). It has been
shown that osteoblastic ECM deposited on titanium
fiber mesh scaffolds induces osteoblastic differentiation
of mesenchymal stem cells (MSCs) in static culture (Datta
et al. 2005). In three-dimensional scaffold, osteoblast-
ECM promotes osteogenic differentiation of embryonic
stem cells and improves osteoblastic differentiation of
marrow stromal cells (Datta et al. 2005; Pham et al. 2008),
and supports adhesion, growth, and ECM production of
osteoblasts in vitro (Tour et al. 2011).
ECM provides supportive microenvironment for mam-
malian cells in vitro. The ECMs of different tissue types
display subtle differences that might provide important
cues for various resident cells; it has been shown that
tissue-specific extracellular matrices promote tissue-
matched cell proliferation and maintenance of cell pheno-
type (Zhang et al. 2009). ECM serves as a reservoir of
growth factors and cytokines, such as BMP, fibroblast
growth factor, and vascular endothelial growth factor;
these key molecules bind to either polysaccharide or pro-
tein constituents of ECM (Suzawa et al. 1999; Pike et al.
2006; Faure et al. 2008). These bioactive proteins/peptides
binding to ECM regulate cell proliferation and differenti-
ation, which suggests that ECMs produced in vitro display
bioactivities, such as proliferative effect and inductive po-
tential. However, the in vitro bioactivities of various ECMs
were not fully understood.
This study was carried out to compare the bioactivities
of two representatively different ECMs: osteoblast-
derived ECM and cardiac fibroblast-derived ECM. The
two ECMs which were coated on cell culture plates,
were prepared respectively. Then, BMSCs or MC3T3-E1
pre-osteoblastic cells were cultured on the plates
covered with the different ECMs, and these cells were
examined for proliferation and osteogenic differentiation
respectively.
Material and methods
This study was approved by The Institutional Animal
Care and Use Committee of Tianjin Institute of Medical
Equipment. All experimental animals were cared for
according to the Guide for the Care and Use of Laboratory
Animals published by National Institute of Health of USA.
Isolation and culture of cardiac fibroblasts
Cardiac fibroblasts from ventricles of neonatal C57BL/6
mouse hearts were isolated and cultured according to a
well-established method (Pan et al. 1999). Briefly, hearts
from neonatal mice were removed, minced and tryp-
sinized at 37°C with gentle stirring in PBS containing
0.25% trypsin (Invitrogen). Then, the cells were centrifuged
and resuspended in complete α-MEM medium supple-
mented with 10% fetal calf serum and 1% penicillin-streptomycin (Invitrogen). After incubation at 37°C for 45
min, the attached cells (most of them were cardiac
fibroblast) were prepared. After 3 passages of subculture,
over 95% of cells were identified as cardiac fibroblasts
by anti-α-sarcomeric actin and anti-vimentin antibody
immunostaining.
Preparation of osteoblast-ECM and cardiac fibroblast-ECM
Osteoblasts were derived from MC3T3-E1 cells (clone 4,
ATCC catalogue number CRL-2593; ATCC Teddington,
UK), a mouse monoclonal pre-osteoblastic cell line that
has been shown to differentiate into osteoblasts and
osteocytes (Sudo et al. 1983; Franceschi and Iyer 1992).
For differentiation, the cells grown to confluence were
maintained for further 8 days in complete a-MEM
medium supplemented with 10% fetal calf serum and 1%
penicillin-streptomycin and in the presence of 280 μmol/L
ascorbic acid, 10 mmol/L β-glycerophosphate and
0.1 μmol/L dexamethasone (Sigma). Cardiac fibroblasts
grown to confluence were maintained for further 8 days in
complete a-MEM medium supplied with 280 μmol/L
ascorbic acid.
The cells were removed according to an established
method (Shirasuna et al. 1993), with some modifications.
Briefly, the cultures of cardiac fibroblasts and osteoblasts
were washed with PBS respectively, the cells were re-
moved by incubation for 3 min with PBS supplemented
with 0.5% Triton X-100 and 10 mmol/L NH4OH, and
then washed three times with PBS. The ECMs attached
to the dishes were treated with 100 units/ml DNase
(Sigma-Aldrich, St. Louis, MO, USA) for 1 h, and the
resulting ECMs were rinsed with PBS, observed by
inverted microscopy. Then the plates coated with ECM
were stored at 4°C. Some of the ECMs coating the wells
were fixed with 3% paraformaldehyde, and stained with
Van Gieson (VG) Histochemical Staining Kit (Nanjing
Jiancheng Biotechnology Co. Ltd, China, containing
hematoxylin solution) to dye the collagen fibers red, and
nuclei blue. The plates or wells without ECM were the
control groups in the experiment illustrated below.
Cellular adhesion assays
BMSCs were seeded into ECM-coated 24-well cell
culture plates coated with different ECMs, allowed to
adhere for 2 h at 37°C, then washed gently with PBS to
remove non-adherent cells; the adherent cells were not
confluent. After incubation with 0.5mg/ml MTT (3-(4,
5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide,
Promega, USA) solution provided (0.30 mL/well)) for two
hours at 37°C, the cells were washed with PBS, and 0.30
mL acidic isopropanol (0.04 mol/L M HCl in absolute
isopropanol) was added to each well; the plates were
shaken to dissolve the converted dye completely. Then the
absorbance was measured at 570 nm on an enzyme-linked
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potential of BMSCs on ECM was expressed as absorbance
at 570 nm (Abs570nm).
Proliferation assays
The BMSCs (Cyagen Biosciences, USA) of passage four,
1.0 × 104 per well, were plated into 24-well cell culture
plates coated with different ECMs. The MTS CellTiter 96®
AQueous One Solution cell proliferation assay kit
(Promega, Madison, USA) was used to assay for living
cells, according to the instructions of the manufacturer.
After incubation for 1.5 h at 37°C, the plates were read on
an enzyme-linked immunosorbent assay reader at 490
nm. The absorbance at 490 nm (Abs490nm or OD490nm)
was used as a measure of living cell population size; the
quantity of MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carbo-
xymethoxyphenyl)-2- (4-sulfophenyl)-2H-tetrazolium, inner
salt) formazan product expressed as OD490nm is directly
proportional to the number of live cells.
ALP activity assay
After trypsinization and centrifugation, the cells were lysed
by brief sonication on ice in a lysis buffer (10 mmol/L
HEPES, 250 mmol/L sucrose, 5 mmol/L Tris–HCl, 0.1%
TritonX-100, pH 7.5). The ALP activity of the lysates was
assayed with ALP Activity Assay Kit (Nanjing Jiancheng
Biotechnology Co. Ltd, China) at 25°C, according to the
manufacturer’s protocol. ALP activity of each sample was
normalized to protein concentration.
Measurement of extracellular deposition of calcium
Calcium deposition in the 24-well plates was measured
using a calcium assay kit (Nanjing Jiancheng Biotechnology
Co. Ltd, China). Briefly, after removal of the BMSCs seeded
in the plates coated with different ECMs, the wells of the
plate were washed with deionized distilled water, and then
incubated overnight in the presence of 0.5 M acetic acid. A
standard curve was generated using serial dilutions of
CaCl2, and the calcium deposited was quantified as μg
Ca2+ equivalent per well. Before re-seeding the cells,
the calcium of the coated ECM in each well of cell
culture plate was assayed. The calcium deposition
content of the ECM without re-seeded cells was
subtracted, then the remnant calcium content was
secreted by the BMSCs which seeded on the ECMs.
Western blot analysis of BMSCs
After centrifugalization, cell lysates were harvested using
RIPA lysis buffer containing protease inhibitors (pH 7.4, 50
mM Tris, 150 mM NaCl, 1% NP-40, 0.1% sodium dodecyl
sulfate, 0.5% sodium deoxycholate, and protease inhibitors
in the buffer: 0.5 μg/ml leupeptin, 1 mM ethylenediamine-
tetraacetic acid, 1 mM Na3VO4, 1 mM phenylmethylsul-
fonyl fluoride, 2 mM sodium pyrophosphate and 25 mMβ-glycerophosphate) (Beijing Biomed Co. Ltd, China). The
protein concentration of the lysates was measured
according to bicinchoninic acid assay (BCA) method, and
equal amounts of proteins were separated by sodium
dodecyl sulfate polyacrylamide gel electrophoresis and
electro-transferred onto polyvinylidene difluoride mem-
branes (Millipore, Bedford, MA, USA). After blocking with
5% skim milk, the membranes were incubated overnight
respectively with the mouse anti-osteopontin (SC21742,
1:500; Santa Cruz, Santa Cruz, USA) and rabbit anti-BMP-
2 (BA0585, 1:500; Boster, Wuhan, China), then washed
with PBS and incubated with horseradish peroxidase-
conjugated secondary antibody. The immunoreactive
bands were visualized using an enhanced chemilumines-
cence detection kit (Santa Cruz Biotechnology, Santa Cruz,
CA, USA). Optical density of the protein bands was
determined with Gel Doc 2000 (Bio-Rad, CA, USA). The
expression of glyceraldehyde3-phosphatedehydrogenase
(GAPDH) of the cells was used as a loading control, data
were normalized against those of corresponding GAPDH.Knockdown of BMP-2 or FGF-2 with small hairpin RNA
(shRNA) interfering
Small interfering RNA targeting mouse BMP-2 (shBMP2)
and FGF-2 (shFGF2) was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). MC3T3-E1 pre-
osteoblastic cells (60%-70% confluence) were transfected
with shBMP2 (shFGF2) or control shRNA (shCtl) using
High-Fect Transfection Reagent (Beijing Cowin Bioscience
Co., Ltd., Beijing, China), according to the manufacturer’s
recommendations. Two days after transfection, follow-
ing experiments (ALP activity assay, Western blot,
real-time PCR and proliferation assays) were performed
at indicated time.Real-time polymerase chain reaction (PCR)
Total RNA was extracted with Trizol (Invitrogen, USA),
then used for the first strand cDNA synthesis using
Rever TraPlus Kit (TOYOBO, Japan). Real time PCR was
performed to determine the mRNA levels of runt-related
transcriptional factor 2 (Runx 2), osteocalcin (OCN) and
glyceraldehyde3-phosphatedehydrogenase (GAPDH, a
housekeeping gene) was used as an internal control. The
reaction was conducted using SYBR Green I PCR Mix
(Invitrogen) on an Applied Biosystems 7900 Real Time
PCR System, according to the manufacturer’s instructions.
Primer sequences are listed in Table 1. The amplification
reaction included three steps, (1) 94°C for 3 min; (2) 94°C
for 15 s; and (3) annealing and extension at each annealing
temperature for 30 s. The steps 2 and 3 were repeated for
40 cycles. Using the relative quantitative method (2-ΔΔCt),
the expression levels of the PCR products of interest rela-
tive to those in the control group were calculated.
Table 1 Primers used for Real-Time PCR analysis





GAPDH F: ACCCATCACCATCTTCCAGGAG 159
R: GAAGGGGCGGAGATGATGAC
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The data were presented as mean ± standard devi-
ation, and analyzed by SPSS10.0 program (Chicago,
IL, USA). One-way analysis of variance (ANOVA)
with a post-hoc test was performed, and the statistical
differences between the two groups were determined
by the Student’s t test. A value of P < 0.05 was con-
sidered statistically significant. All experiments were
repeated at least 3 times, and representative experi-
ments are shown.Results
ECM preparation
The results of immunostaining showed that the isolated
cells were positively stained with anti-vimentin antibody
and negatively stained with anti-α-sarcomeric actin anti-
body (Figure 1). The result indicated that the cells we
cultured were cardiac fibroblasts.
After treatment with PBS containing 0.5% Triton X-
100 and 0.10 M NH4OH, all the cells were removed,
leaving behind the ECM. Under inverted microscope,
the osteoblast- and fibroblast-ECM looked the same
(Figure 2). VanGieson staining results (with VanGieson
Kit containing hematoxylin solution) showed no visible
nuclei but large numbers of collagen fibers could be seen
in both types of ECM (Figure 2). No difference was
found between the staining results.Figure 1 Cardiac fibroblasts were identified. Cardiac fibroblasts in vitro
-sarcomeric actin (C) antibody immunostaining. (bar: 100 μm).BMSCs proliferation and adhesion assays
The results of cellular adhesion assays showed that
the adhesion potential of BMSCs in osteoblast-ECM
was nearly the same as in cardiac fibroblast-ECM
(Figure 3A).
The proliferation activity was examined using the
MTS assay and expressed as OD490nm. The results of
the MTS assay indicated that the proliferative effect of
cardiac fibroblast-ECM was stronger than that of
osteoblast-ECM and control group (without ECM coat-
ing), and the proliferative effect of osteoblast-ECM was
stronger than control group (Figure 3B).
Osteoblastic differentiation of BMSCs seeded on ECMs
To investigate whether the ECMs could stimulate osteo-
blastic differentiation of BMSCs, the cells were seeded
on ECM-coated plates. ALP activity assay was performed
after 3, 5 and 7 days of incubation, and extracellular
calcium content assay was performed after 7 days. The
results showed that the ALP activity in the cells grown
in osteoblast-ECM coated plates was higher than in the
cells cultured with cardiac fibroblast-ECM and in the
control group (Figure 4A).
After 7 days of growth, the calcium deposition of the
cells cultured on osteoblast-ECM coated plate was more
substantial than in other two groups (Figure 4B).
The immunoblotting data demonstrated that osteopontin
protein expression levels of BMSCs seeded on osteoblast-
ECM were the highest in the three groups (after 5 days of
culture, Figure 5). The BMP-2 level was the highest 5 days
later (Figure 5).
The levels of Runx2 and OCN mRNA in BMSCs
seeded on osteoblast-ECM were both higher than in
the cells grown on cardiac fibroblast-ECM and in the
control group (after five and seven days of growth,
Figure 6).
In addition, the osteoinductive potential of cardiac
fibroblast-ECM was very limited, it is nearly as low as
control group without ECM coating (Figures 4, 5, 6).were observed (A) and identified using anti-vimentin (B) and anti-α
Figure 2 Preparation and VG histochemical staining of osteoblast-ECM and fibroblast-ECM. Osteoblasts and fibroblasts were removed after
treatment with PBS containing 0.5% Triton X-100 and 0.10 M NH4OH, and the ECMs formed on the surfaces were revealed. VG staining with VG
kit containing hematoxylin solution showed collagen fibers which were stained red and no nuclei. (bar: 100 μm).
Figure 3 Assay of relative adhesion potential and proliferation of BMSCs grown on osteoblast-ECM and fibroblast-ECM. A: the relative
adhesion potential was assayed with MTT reagent, the results indicated that the adhesion potential of BMSCs grown on cardiac fibroblasts-ECM
was nearly the same as on osteoblast-ECM. B: The proliferative acticity was assayed with MTS reagent, the results indicated the proliferation of
BMSCs was the highest on the fibroblast-ECM, and the proliferation on osteoblast-ECM was higher than control group. * P <0.05, **P <0.01,
between the indicated groups, n = 7 per group, control group, no ECM coated.
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Figure 4 Alkaline phosphatase (ALP) activity and extracellular calcium (Ca) deposition of BMSCs seeded on the two different ECMs.
ALP activity was detected using the p-nitrophenyl phosphate method. After 5, 7 days of culture, the result showed that the ALP activity of BMSCs
grown on osteoblast-ECM is higher than for other groups (A). After 7 days of culture, the Ca content was assayed using the methyl thymol blue
complexon method, the result indicated that BMSCs grown on osteoblast-ECM secrete more Ca than the cells in other groups (B). **P <0.01, * P <0.05,
between the indicated groups, n = 7 per group.
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MC3T3-E1 cells transfected with shBMP2 or shFGF2 and
re-seeded on ECMs
Transfection with shBMP-2 reduced the ALP activity
and Runx2 mRNA level of MC3T3-E1 cells seeded on
plates without ECM coating after 3 and 5 days ofFigure 5 Western blot analysis of BMP-2 and osteopontin in BMSCs s
expression levels of osteopontin (normalized to GAPDH) are higher in BMS
culture, the protein level of BMP-2 is higher than other group. * P <0.05, **growth. On the contrary, shBMP-2 had little effect on
ALP activity and Runx2 mRNA level of MC3T3-E1 cells
seeded on osteoblast-ECM coated plates (Figure 7). The
results indicated knockdown of BMP-2 hardly affected
on osteoblastic differentiation of MC3T3-E1 cells re-
seeded on osteoblast-ECM.eeded on the ECMs. After 5, 7 days of culture, the relative protein
Cs seeded on osteoblast-ECM than in other groups. After 5 days of
P <0.01, between the indicated groups, n = 5 per group.
Figure 6 mRNA expression levels of Runx2 and OCN in BMSCs seeded on the ECMs. After 5 and 7 days of culture, the relative mRNA level
was assayed using real time polymerase chain reaction, Runx2 mRNA and OCN mRNA are the highest levels in BMSCs seeded on osteoblast-ECM,
* P <0.05, **P <0.01, between the indicated groups, n = 6 per group.
Figure 7 Transfection with shBMP-2 affected ALP activity and Runx2 mRNA level of MC3T3-E1 cells re-seeded on osteoblast-ECM. A,
shBMP-2 reduced BMP-2 protein level of MC3T3-E1 cells. B, shBMP-2 lowered ALP activity of MC3T3-E1 cells seeded on cell culture plates without
ECM coating (no ECM) , but had little effect on MC3T3-E1 cells seeded on osteoblast-ECM coated plates (ECM). C, shBMP-2 reduced Runx2 mRNA
level, but had little effect on the cells seeded on osteoblast-ECM. ** P <0.01, *P <0.05, between the indicated groups, n = 5 per group.
Guo et al. SpringerPlus 2013, 2:303 Page 7 of 10
http://www.springerplus.com/content/2/1/303
Guo et al. SpringerPlus 2013, 2:303 Page 8 of 10
http://www.springerplus.com/content/2/1/303The results of shFGF-2 were similar to shBMP-2,
shFGF-2 reduced proliferative activity of the cells on no
ECM-coated plates after 2 and 3 days of growth, and its
effect on proliferative activity of the cells on fibroblast-
ECM coated plates was very limited (Figure 8). The
results indicated knockdown of FGF-2 had little effect
on proliferation of MC3T3-E1 cells re-seeded on
fibroblast-ECM.
Discussion
ECM affects growth and differentiation of stem cells; it
is one of the most important components of the stem
cell niche (Metallo et al. 2007; Peerani and Zandstra
2010). BMSCs, the pluripotent stromal cells derived
from bone marrow, can rapidly multiply billion-fold in a
culture, and can be induced to differentiate into a variety
of cell types, including osteoblasts (Prockop 1997;
Jaiswal et al. 2000; Jiang et al. 2000). Considering
multilineage differentiation potential of BMSCs and the
microenvironment provided by ECMs for mammalian
cells in vitro, the effect of different cell-derived ECMs
(such as osteoblast-ECM and cardiac fibroblast-ECM)
on the growth and differentiation of BMSCs in vitro is
of the utmost importance.Figure 8 Transfection with shFGF-2 affected proliferation of MC3T3-E
level of MC3T3-E1 cells. B, shFGF-2 lowered proliferative activity of MC3T3-E
but had little effect on MC3T3-E1 cells seeded on fibroblast-ECM coated pl
per group.ALP, BMP-2, osteopontin, Runx 2, OCN and extracellu-
lar calcium deposition, all were marker of osteogenic
differentiation (Beck et al. 2000; Wu et al. 2009; Rider and
Mulloy 2010; Mahalingam et al. 2011), so they were
assayed to evaluate osteoblastic differentiation in our
previous studies (Guo et al. 2011, 2012). In this study, to
investigate osteogenic differentiation of BMSCs seeded on
ECMs, ALP activity, the levels of BMP-2 and osteopontin
protein, mRNA expression of Runx2 and OCN, and extra-
cellular calcium deposition were all analyzed.
We compared osteoblastic differentiation of BMSCs
seeded on osteoblast-ECM and cardiac fibroblast-ECM.
The activity of ALP and calcium deposition of BMSCs
grown in the plates coated with osteoblast-ECM were
higher than in other groups. BMSCs seeded on osteoblast-
ECM had also the highest protein levels of BMP-2,
osteopontin, and mRNA for Runx2 and OCN. These data
demonstrate that osteoblast-ECM is more suitable for
osteogenic differentiation than fibroblast-derived ECM.
However, in this study, the cardiac fibroblast-derived
ECM had much stronger proliferative effect on BMSCs
than osteoblast-derived ECM. Considering that the rela-
tive adhesion potentials of BMSCs were nearly same on
the two ECMs, the results indicated that cardiac1 cells seeded on fibroblast-ECM. A, shFGF-2 reduced FGF-2 protein
1 cells seeded on cell culture plates without ECM coating (no ECM),
ates. ** P <0.01, *P <0.05, between the indicated groups, n = 5
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osteoblast-ECM. Compared with control group, the
osteoblast-ECM also had proliferative effect.
BMP-2, accumulated in collagen-rich extracellular
matrices produced by osteoblasts or in bone matrix, can
induce differentiation of stem and mesenchymal cells into
osteogenic cells capable of producing bone (Suzawa et al.
1999; Granjeiro et al. 2005). Covalently immobilized
BMP-2 on a NHS-functionalized self-assembled mono-
layer, promotes the osteoblast phenotype in C2C12 cells
(Pohl et al. 2012). FGF-2, an ECM-bound growth factor,
binds to heparan sulfate glycosaminoglycan of ECM
(Vlodavsky et al. 1987; Duchesne et al. 2012), the extracel-
lular matrix–growth factor complexes play an important
role in cell proliferation (Clark 2008). In this study,
although knockdown of BMP-2 or FGF-2 inhibited osteo-
blastic differentiation or proliferation of MC3T3-E1 cells.
The knockdown hardly effected osteoblastic differenti-
ation or proliferation of MC3T3-E1 cells seeded on
osteoblast-ECM or fibroblast-ECM. These results indi-
cated osteoblast-ECM or fibroblast-ECM had enough
bioactivity to induce osteoblastic differentiation or proli-
feration of MC3T3-E1 cells even the secretion of BMP-2
or FGF-2 was reduced significantly, at least in early time.
It is probably that BMP-2 or FGF-2 in the two ECMs
induces the differentiation or proliferation. In future study,
we will investigate the probability.
Most components of the natural ECM have structural
characteristics in nanometer dimensions, and the organi-
zation of cells and the corresponding tissue features are
highly dependent on the ECM’s architecture Liu et al.
(2009). For example, collagen is the major protein of the
ECM, it arranges into nanofibers ranging from 50 to
500nm in diameter, its architecture plays a great role in
cell behavior (Holzwarth and Ma 2011). This nanoscale
fibrillar structure has been shown to be important for
cell attachment, proliferation, and differentiation (Smith
et al. 2009; Holzwarth and Ma 2011). In this study, the
VG staining showed the collagen fibers in the two
ECMs. In the future, we will investigate the relationship
between bioactivity of ECM and the collagen’s architec-
ture in nanometer dimensions.
In conclusion, the ECMs from two different sources
present diverse bioactivity, the osteoblastic ECM has
better osteoinductive potential and lower proliferative
effect than fibroblastic ECM, knockdown of growth factors
(BMP-2 or FGF-2) hardly influences differentiation and
proliferation of re-seeded cells on the ECMs.Abbreviations
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